A phase I evaluation of multitargeted antifolate (MTA,...

Cancer Chemotherapy and Pharmacology 1999 / 09 Vol. 44; Iss. 5

A phase I evaluation of multitargeted antifolate (MTA, LY231514), administered every 21 days, utilizing the modified continual reassessment method for dose escalation

David A. Rinaldi, John G. Kuhn, Howard A. Burris, F. Andrew Dorr, Gladys Rodriguez, S. Gail Eckhardt, Suzanne Jones, James R. Woodworth, Sharyn Baker, Connie Langley, David Mascorro, Trent Abrahams, D
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
44
Language:
english
Pages:
9
DOI:
10.1007/s002800050992
Date:
September, 1999
File:
PDF, 142 KB
english, 1999
Conversion to is in progress
Conversion to is failed